STAT3 and atherosclerosis: Abnormal activation of STAT3 regulates the progression of atherosclerosis through affecting endothelial cells, macrophages, inflammation, etc., and targeted inhibition of STAT3 is consequently considered as a potential treatment strategy for atherosclerosis.